002762 Jinfa Labi Maternity & Baby Articles
- 6.49
- -0.05-0.76%
Jinfa Labi Maternity & Baby Articles News
Golden Rabbi (002762.SZ): Net profit of 487,500 yuan in the first quarter decreased by 91.01% year on year
On April 17, Ge Longhui (002762.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 43.5025 million yuan, down 14.86% year on year; net profit attributable to shareholders of listed companies was 487,500 yuan, down 91.01% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 496,900 yuan, down 89.15% year on year; basic earnings per share were 0.001 yuan.
The A-share baby concept strengthened in early trading and baby-friendly rooms rose or stopped
Gelonghui, April 3 | Baby-friendly rooms went up and down, and the blonde rabbi, Mijim, Xinhua Jin, and Kid Wang followed suit. According to the news, the National Development and Reform Commission, the Ministry of Civil Affairs, and the National Health Commission revised and issued the “14th Five-Year Plan” on April 2 to actively respond to population aging and childcare construction. Among them, the special action construction project for inclusive childcare services uses a fixed subsidy method and is supported according to the standard of 20,000 yuan for each additional nursing place.
The baby concept changed in the afternoon, and the blonde rabbi went up and down in a straight line
Gelonghui, March 4 | The A-share baby concept changed in the afternoon, and the blonde rabbi went up and down. Previously, Hanshang Group went up and down, and Babycare, Kangzhi Pharmaceutical, David Medical, and Carman Apparel followed suit. According to the news, “speeding up the improvement of the maternity support policy system” is an important task for the Central Economic Work Conference to deploy people's livelihood work in 2024. Member He Dan, director of the China Population and Development Research Center, suggested making comprehensive use of support measures such as fiscal, medical care, insurance, and education to reduce the burden of childbearing, parenting, and education on families.
Blonde Rabbi (002762.SZ): Pre-loss of 16 million yuan to 24 million yuan in 2023
Ge Longhui, January 29 | Jin Labi (002762.SZ) announced the 2023 annual results forecast. Net profit loss attributable to shareholders of listed companies during the reporting period was 16 million yuan to 24 million yuan, loss of 882.393 million yuan for the same period last year; net profit loss after deducting non-recurring profit and loss of 18 million yuan to 26 million yuan, loss of 97.072 million yuan for the same period last year; basic earnings loss per share was 0.05 yuan/share — 0.07 yuan/share. Affected by various factors such as the market environment, Guangdong Hanfei Hospital Investment Co., Ltd. (hereinafter referred to as “Han Fei Investment”) in 2023
A-share medical and aesthetic concepts strengthened, and blonde rabbis rose and stopped
Gelonghui, January 24 | Golden Rabbi rose and stopped. Previously, Jiangsu Wuzhong had 2 consecutive games. Langzi shares, Langsha shares, Jinbo Biotech, and Freida followed suit. According to the news, on January 22, Jiangsu Wuzhong issued an announcement. Its grandson Datou Medical received the “Medical Device Registration Certificate” issued by the State Drug Administration. AestheFill, a polylactic acid facial filler, was officially approved and will be officially marketed in mainland China in the first half of 2024.
The A-share infant concept bucked the trend and boosted the rise and fall of Yuexin Health
Glonghui, January 10 | Yuexin Health, Golden Rabi, Tongda Chuangzhi rose and stopped, and Kyodo Pharmaceuticals, Sharp Ace, Hanshang Group, and Langzi Co., Ltd. followed suit. According to the news, currently, some places have included assisted reproductive technology in medical insurance. On January 8, the website of the Gansu Provincial Health Insurance Administration announced the “Notice on Including Some Therapeutic Assisted Reproduction Medical Service Programs in the Scope of Basic Medical Insurance and Work Injury Insurance Fund Payments”. Starting February 1, the province will include 12 therapeutic assisted reproductive medical service programs, including egg retrieval, in the scope of basic medical insurance and workers' injury insurance fund payments.
A-share medical and aesthetic concepts are partially picking up, Aimeike surges 7%
Glonghui, January 8 | Aimeike surged 7%, Golden Rabi rose more than 5%, and Huaxi Biotech, Langzi Shares, and Shuiyang shares surged. According to the news, Ameke announced its 2023 annual results forecast. It is expected to achieve net profit of 1.81 to 1.9 billion yuan, an increase of 43%-50% year-on-year, and a 49%-56% year-on-year increase after deducting non-net profit.
Labi Maternity & Baby Articles Resumes Operation of Cosmetics Factory
Jinfa Labi Maternity & Baby Articles' (SHE:002762) cosmetics factory for its Rebi Labi brand resumed operation after receiving approval from the Food and Drug Administration of China's Guangdong Provi
Blonde rabbi (002762.SZ): Cosmetics factories under the Baby Rabbi brand resume production and operation
Glonghui on December 6 | Goldenrabi (002762.SZ) announced that on December 6, 2023, the company received a notice from the Guangdong Drug Administration on its official website agreeing to resume production by our cosmetics factory (No. 93 of 2023): According to Section 60 of the “Regulations on the Supervision and Administration of Cosmetics” and Article 59 of the “Measures for the Supervision and Administration of Cosmetics Production and Operation”, the Guangdong Drug Administration organized an on-site rectification of the cosmetics factory under the Babylabi brand Check and say “the company has
Blonde rabbi (002762.SZ): No foreign export business
Gelonghui November 20: Golden Rabbi (002762.SZ) said on the investor interactive platform that currently the company's products are mainly sold to the domestic market, and there is no foreign export business yet.
Jinfa Labi to Cooperate With Provincial Laboratory for Technology Development
Jinfa Labi Maternity & Baby Articles (SHE:002762) agreed to cooperate with the Guangdong Provincial Laboratory of Chemistry and Fine Chemicals in researching and developing patented technologies owned
Ruby Jin (002762.SZ): Plans to establish a long-term and stable cooperative relationship with Shantou Laboratory in basic applied research in the field of chemistry and chemistry
On November 1, Gelonghui (002762.SZ) announced that in order to continue product and technology research and development and reserve, and promote new product research and development to actively move closer to new materials, new processes, and new technology, Golden Rabbi Maternal and Child Products Co., Ltd. and the Guangdong Laboratory of Chemistry and Fine Chemicals (“Shantou Laboratory” for short) recently signed a “Strategic Cooperation Agreement” after friendly negotiations. The two sides will establish a long-term and stable cooperative relationship in the field of chemistry and applied basic research. Achieve cooperation in scientific and technological innovation, transformation of achievements, and talent training through resource sharing, complementary advantages, and common development
Golden Rabbi (002762.SZ) released results for the first three quarters, with net profit of 4.148,200 yuan, a year-on-year decrease of 59.76%
Golden Rabbi (002762.SZ) released the report for the first three quarters. During the reporting period, the company achieved revenue of 150 million dollars...
Golden Rabbi (002762.SZ): J3 Fund has completed cancellation matters
Golden Rabbi (002762.SZ) announced that Hong Kong Rabbi, a wholly-owned subsidiary of the company, recently received its investment in J3C...
Jinfa Labi Halts Production at Cosmetics Plant After Authorities Identify Lapses
Jinfa Labi Maternity & Baby Articles (SHE:002762) said authorities from China's National Medical Products Administration have identified certain concerns including lapses in quality assurance and cont
The blonde rabbi (002762.SZ) received the flight inspection results from the State Drug Administration and requested continued rectification
Golden Rabbi (002762.SZ) issued an announcement. On August 16-17, 2023, the State Drug Administration and Guangzhou...
Jinfa Labi Maternity & Baby Articles to Boost Stake in Hospital Management Firm to 49% For 59.5 Million Yuan
Jinfa Labi Maternity & Baby Articles (SHE:002762) has agreed to acquire a 13% stake in a local hospital management company for 59.5 million yuan, boosting its ownership to 49%. The Chinese producer of
Golden Rabbi (002762.SZ): Plans to purchase 13% of Guangdong Han Fei's shares for 59.5059 million yuan
GLONGHUI, September 12 | Golden Rabbi (002762.SZ) announced that in order to promote the implementation of the “product+service+Internet” strategy, steadily advance the company's planning and construction in the field of medical and aesthetic services, and enhance the competitiveness of the “product+service” model, the company plans to purchase 59.5059 million yuan of Shanghai Jianermei Enterprise Management Consulting Partnership (Limited Partnership) (“Shanghai Jianermei”, “transferor”), 13% of the shares held by Guangdong Hanfei Hospital Investment Co., Ltd. (“Target Company” or “Guangdong Han Fei” for short).
Golden Rabbi (002762.SZ): Net profit fell 29.35% in the first half of the year to 7.5726 million yuan
GLONGHUI, August 24 | Golden Rabbi (002762.SZ) announced its 2023 semi-annual report. Operating income for the reporting period was 103 million yuan, down 15.65% year on year; net profit attributable to shareholders of listed companies was 7.7526 million yuan, down 29.35% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 5.7074 million yuan, down 40.68% year on year; basic earnings per share were 0.02 yuan.
The medical, aesthetic, and cosmetics sectors boosted, and the blonde hair ratio rose and stopped rapidly
On July 28, | Golden Rabbi quickly rose and stopped. Shui Yang shares rose more than 13%, and Anke Biotech, Langzi shares, and Lafonjiahua continued to rise.
Analysis
Price Target
No Data
